CLASS 4 CAUTION IN USE - HYOSCINE BUTYLBROMIDE 20 MG FILM-COATED TABLETS

Morningside Healthcare Limited has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged in batch 22237001 of Hyoscine Butylbromide 20 mg Film-coated Tablets. Some packs within the batch may contain a PIL for Midodrine Hydrochloride 2.5 mg & 5 mg Tablets. The issue was identified due to a market complaint, which noted that a Midodrine Hydrochloride 2.5 mg & 5 mg Tablets leaflet had been found in a pack of Hyoscine Butylbromide 20 mg Film-coated Tablets, batch 22237001, expiry date 04/2025.

MHRA drug alert date: 21st November 2022

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-morningside-healthcare-limited-hyoscine-butylbromide-20-mg-film-coated-tablets-el-22-a-slash-48?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=cfd26f4f-9046-4674-9924-980b00650278&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information:

For further information please contact: Morningside Healthcare Ltd, Morningside House, Unit C Harcourt Way, Meridian Business Park, Leicester, LE19 1WP,

Telephone: +44 (0)116 2045950

For medical information enquiries, please contact: medicalenquiry@morningsidehealthcare.com or Telephone +44 (0)116 478 0322 and for all stock enquiries, please contact Telephone: +44 (0)1162045950